SELPLG report

Query

Invalid input gene. Please select from the suggestions.

I. Expression across cell types

Cell ontologyData table

Name	Number of supported studies	Average coverage
natural killer cell	28 studies	34% ± 13%	Explore
CD8-positive, alpha-beta T cell	21 studies	33% ± 13%	Explore
regulatory T cell	21 studies	43% ± 18%	Explore
CD4-positive, alpha-beta T cell	21 studies	29% ± 12%	Explore
non-classical monocyte	20 studies	42% ± 15%	Explore
plasmacytoid dendritic cell	20 studies	49% ± 16%	Explore
classical monocyte	16 studies	31% ± 12%	Explore
mature NK T cell	15 studies	35% ± 10%	Explore
CD16-positive, CD56-dim natural killer cell, human	14 studies	45% ± 14%	Explore
conventional dendritic cell	12 studies	28% ± 11%	Explore
T cell	12 studies	27% ± 9%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	12 studies	32% ± 10%	Explore
gamma-delta T cell	12 studies	31% ± 12%	Explore
CD16-negative, CD56-bright natural killer cell, human	11 studies	30% ± 11%	Explore
CD8-positive, alpha-beta memory T cell	10 studies	34% ± 12%	Explore
macrophage	10 studies	23% ± 8%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	10 studies	31% ± 11%	Explore
mucosal invariant T cell	9 studies	34% ± 10%	Explore
CD4-positive, alpha-beta memory T cell	9 studies	36% ± 17%	Explore
effector memory CD8-positive, alpha-beta T cell	8 studies	30% ± 11%	Explore
dendritic cell	8 studies	34% ± 11%	Explore
monocyte	7 studies	27% ± 6%	Explore
microglial cell	7 studies	29% ± 10%	Explore
effector CD8-positive, alpha-beta T cell	6 studies	40% ± 14%	Explore
effector memory CD8-positive, alpha-beta T cell, terminally differentiated	5 studies	35% ± 16%	Explore
exhausted T cell	5 studies	36% ± 14%	Explore
neutrophil	5 studies	20% ± 4%	Explore
plasma cell	4 studies	26% ± 10%	Explore
myeloid cell	4 studies	23% ± 5%	Explore
effector CD4-positive, alpha-beta T cell	4 studies	67% ± 9%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	53% ± 19%	Explore
CD4-positive, alpha-beta cytotoxic T cell	3 studies	36% ± 23%	Explore
central memory CD8-positive, alpha-beta T cell	3 studies	33% ± 19%	Explore
plasmablast	3 studies	44% ± 16%	Explore
double negative thymocyte	3 studies	40% ± 7%	Explore

II. Expression across tissues

sc-RNAseq dataData table

Name	Number of supported studies	Average coverage
peripheral blood	14 studies	31% ± 9%	Explore
brain	3 studies	27% ± 15%	Explore

Bulk RNAseq dataData table

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
lung	100%	3331.54	577 / 578	94%	35.69	1083 / 1155
breast	78%	458.86	359 / 459	96%	36.86	1073 / 1118
brain	68%	626.28	1805 / 2642	98%	61.51	691 / 705
intestine	80%	720.21	777 / 966	83%	20.50	438 / 527
bladder	86%	550.95	18 / 21	68%	18.87	343 / 504
stomach	70%	395.84	252 / 359	83%	21.92	238 / 286
thymus	53%	303.84	347 / 653	90%	38.72	546 / 605
esophagus	64%	351.96	932 / 1445	75%	14.50	137 / 183
kidney	45%	328.18	40 / 89	90%	31.21	812 / 901
skin	49%	199.78	885 / 1809	85%	34.36	403 / 472
adrenal gland	82%	547.94	212 / 258	49%	7.61	113 / 230
prostate	63%	304.58	154 / 245	64%	9.94	323 / 502
uterus	45%	213.42	76 / 170	82%	21.51	378 / 459
pancreas	11%	52.48	36 / 328	92%	54.14	163 / 178
ovary	23%	91.97	42 / 180	79%	17.83	338 / 430
lymph node	0%	0	0 / 0	100%	103.66	29 / 29
peripheral blood	100%	44882.50	929 / 929	0%	0	0 / 0
spleen	100%	8729.34	241 / 241	0%	0	0 / 0
adipose	95%	998.84	1142 / 1204	0%	0	0 / 0
tonsil	0%	0	0 / 0	93%	40.67	42 / 45
liver	36%	175.94	82 / 226	51%	9.92	207 / 406
blood vessel	62%	460.22	824 / 1335	0%	0	0 / 0
heart	48%	230.63	411 / 861	0%	0	0 / 0
eye	0%	0	0 / 0	36%	5.86	29 / 80
muscle	3%	12.30	28 / 803	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1